Medicaid dollars can be used on Zika prevention like mosquito repellent

States can use Medicaid funding for items such as condoms and mosquito repellent to prevent the spread of the Zika virus, according to a new letter from CMS.

Allowing states to use existing fund to cover repellent may offer a short-term solution to funding problems for Zika prevention efforts, as Congress is on a break until June 7 after failing to settle a dispute over extra funding for federal agencies.

CMS Director Vikki Wachino wrote that while more common over-the-counter repellents wouldn’t be covered by this guidance, state Medicaid programs could be reimbursed with federal funds when repellents are prescribed by a healthcare professional.

“CDC recommends people use Environmental Protection Agency (EPA)-registered insect repellents with one of the following active ingredients: DEET, picaridin, IR3535, oil of lemon eucalyptus or para-menthane-diol,” Wachino wrote.  

The letter restates existing policy on family planning and contraceptives. Federal Medicaid funding covers up to 90 percent of the costs of those services, like counseling and contraceptives including condoms and intrauterine devices, which Wachino said are all “critical” due to evidence Zika can be spread by sexual contact and cause birth defects like Guillain-Barré syndrome and microcephaly.

According to the Associated Press, two babies with defects linked to the virus have been born in the U.S., one in Hawaii and one in New Jersey. As with all Zika cases in the country so far, the virus had been acquired while traveling. Because of those risks, the Centers for Disease Control and Prevention has recommended pregnant women avoid traveling to Zika-affected countries.

Wachino’s letter also listed other Medicaid-covered services could be used to diagnose Zika.

“For example, if a pregnant women has recently traveled to an area with active mosquito-borne transmission of the Zika virus, her primary care doctor may recommend a blood test,” Wachino wrote. “If positive, her doctor may order an ultrasound to assess the health and development of the fetus. If abnormalities are detected, further testing may be required, including CAT scans and MRIs to ensure the health of the mother and fetus.”

If children are born with Zika-related disabilities, the guidance said they may need physical therapy and long-term rehabilitative care services covered by Medicaid. 

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.